Trial Profile
A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Dec 2023
Price :
$35
*
At a glance
- Drugs Belinostat (Primary) ; Doxorubicin
- Indications Sarcoma; Soft tissue sarcoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors TopoTarget; Valerio Therapeutics
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 28 May 2015 Results presented at the 2015 American Society of Clinical Oncology Annual Meeting, according to an Onxeo media release.
- 28 May 2015 Results published in an Onxeo media release.